Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders. Theranexus’ unique, patented technology is aimed at increasing the efficacy of CNS drugs that have already been approved and are available on the market. Theranexus’ technology is protected, unique, scalable, and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and costs.